{"disease":{"id":"hiv-negative","name":"hiv negative"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01941121","title":"CCTG 593: Testing and Linkage to Care","phase":"NA","overall_status":"COMPLETED","enrollment_count":600,"lead_sponsor_name":"University of California, San Diego","has_results":false},{"nct_id":"NCT03254550","title":"PrEP Demonstration Study in Swaziland","phase":"NA","overall_status":"COMPLETED","enrollment_count":517,"lead_sponsor_name":"Clinton Health Access Initiative Inc.","has_results":false},{"nct_id":"NCT04601649","title":"PrEP Talk: PrEP Uptake With Young Black MSM and Their Close Friends","phase":"EARLY_PHASE1","overall_status":"UNKNOWN","enrollment_count":120,"lead_sponsor_name":"California State University, Dominguez Hills","has_results":false},{"nct_id":"NCT07194902","title":"HIV Self-testing for Partners of HIV-uninfected Postpartum Women","phase":"NA","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT01386489","title":"Immune Responses to Two Experimental HIV Vaccines in Healthy Adults","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT04514484","title":"Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":8,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT03697226","title":"Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection.","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":8,"lead_sponsor_name":"Antiva Biosciences","has_results":false}],"total":7},"guidelines":[],"source":"Drug Landscape verified database"}